SLEEP APNEA &HYPERTENSION--ROLE OF SYMP NERVOUS SYSTEM

$553,542R01FY2000HLNIH

University Of California San Diego, La Jolla CA

Investigators

Linked publications & trials

Paper 27018723 Paper 26402487 Paper 25903538 Paper 25861135 Paper 24269133 Paper 24245839 Paper 24114717 Paper 23036264 Paper 22366585 Paper 22172966 Paper 22140396 Paper 22023437 Paper 21988095 Paper 21925567 Paper 21803621 Paper 21677894 Paper 21398043 Paper 21286497 Paper 21218292 Paper 21203367 Paper 21051684 Paper 20924835 Paper 20841563 Paper 20411694 Paper 20337196 Paper 19533192 Paper 19365284 Paper 19358951 Paper 19319586 Paper 19148690 Paper 19100813 Paper 18835664 Paper 18819754 Paper 18551328 Paper 18516635 Paper 18474758 Paper 18371552 Paper 18220085 Paper 18212172 Paper 18040093 Paper 17992551 Paper 17937582 Paper 17583588 Paper 17580594 Paper 17570260 Paper 17503102 Paper 17478594 Paper 17356087 Paper 17252883 Paper 17178209 Paper 17089145 Paper 16872682 Paper 16770648 Paper 16585412 Paper 16565866 Paper 16317246 Paper 16046361 Paper 15851643 Paper 15802257 Paper 15480091 Paper 15453560 Paper 15385687 Paper 15172212 Paper 14605073 Paper 14555572 Paper 12936048 Paper 12840627 Paper 12837671 Paper 12749554 Paper 12611749 Paper 12571548 Paper 12562583 Paper 12488649 Paper 12405612 Paper 12377835 Paper 12241529 Paper 12094190 Paper 12028210 Paper 12003165 Paper 12001088 Paper 11903860 Paper 11863402 Paper 11843994 Paper 11806675 Paper 11766160 Paper 11763990 Paper 11761349 Paper 11587154 Paper 11573026 Paper 11555525 Paper 11518853 Paper 11485111 Paper 11485106 Paper 11441916 Paper 11296175 Paper 11163547 Paper 11133249 Paper 11082475 Paper 11035863 Paper 11012866

Abstract

DESCRIPTION (adapted from investigator's abstract): This competing renewal examines the effect of chemoreceptor (CHEMO) and sympathetic nervous system (SNS) physiology in four groups of individuals: apneics and non-apneics, with and without hypertension. A total of 80 individuals will be studied in terms of their CHEMO and SNS function, sleep physiology, and quality of life. They will then be randomized to receive either nocturnal oxygen supplementation or nocturnal room-air supplementation and they will be restudied after 24 hours and after one week. Studies will include measurement of plasma and urinary catecholamines, beta adrenergic receptors on lymphocytes, plasma endothelin-1. CHEMO activity will be characterized while breathing room-air, while stimulating CHEMO with a brief period of hypoxia, and while blocking CHEMO with a brief period of hyperoxia. Using tritiated norepinephrine, norepinephrine release rate will be calculated during each of these CHEMO manipulations. Using impedance cardiography, cardiac hemodynamics will be characterized at rest and in response to behavioral stressors. The study will measure heart rate and tidal volume responses to infused isoproterenol. Baroreflexes will be characterized after stimuli that transiently increase and decrease blood pressure. Blood pressure will be characterized with ambulatory blood pressure monitoring. Sleep will be characterized with polysomnography. The effect of nocturnal oxygen treatment will be studied in terms of patient satisfaction, compliance, and quality of life.

View original record on NIH RePORTER →